Healthcare -
Biotechnology - NASDAQ - US
$ 11.12
1.27 %
$ 647 M
Market Cap
-3.92
P/E
CGEM - RESEARCH & DEVELOPMENT
Research & Development CGEM - Cullinan Oncology, Inc.
148 M
LAST VALUE
60.17%
2 YEAR CAGR
72.92%
5 YEAR CAGR
0.00%
10 YEAR CAGR